Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients

Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients

COVID-19 convalescent plasma (CCP) has been the only specific anti-viral therapy against SARS-CoV-2 available for more than one year. Following the negative results from most randomized controlled trials on its efficacy in COVID-19 hospitalized patients and the availability of anti-spike monoclonal...

Full description

Bibliographic Details
Main Authors: Arar, O. (Author), Baldanti, F. (Author), Ballotari, A. (Author), Beccaria, M. (Author), Bertacco, S. (Author), Ferrari, A. (Author), Focosi, D. (Author), Franchini, M. (Author), Gagliardo, T. (Author), Garuti, M. (Author), Ghirardini, M. (Author), Glingani, C. (Author), Greco, G. (Author), Pecoriello, A. (Author), Percivalle, E. (Author), Sammartino, J.C (Author), Santini, T. (Author), Schiavulli, M. (Author), Spreafico, F. (Author), Stefania, M. (Author), Zani, M. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
COVID-19 convalescent plasma
efficacy
SARS-CoV-2
variants of concern
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items